Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2004 Sep 1;9(17):759-68.

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

Author information

1
University of Müster, Department of Medicine, Hematology and Oncology, Albert-Schweitzer-Strasse 33, D-48129 Münster, Germany. s.ries@medigene.com

Abstract

Tumor-selective replicating viruses offer appealing advantages over conventional cancer therapy and are a promising new approach for the treatment of human cancer. The development of virotherapeutics is based on several strategies that each provides a different foundation for tumor-selective targeting and replication. Results emerging from clinical trials with oncolytic viruses demonstrate the safety and feasibility of a virotherapeutic approach and provide early indications of efficacy. Strategies to overcome potential obstacles and challenges to virotherapy are currently being explored and are discussed here. Importantly, the successful development of systemic administration of oncolytic viruses will extend the range of tumors that can be treated using this novel treatment modality.

PMID:
15450242
DOI:
10.1016/S1359-6446(04)03221-0
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center